Presentation TCT 2024 TCT 956: Validation of the VARC-HBR Criteria in TAVI Patients on Oral Anticoagulation Presenter: Daniel Overduin October 30, 2024
Presentation TCT 2024 TCT 242: Prospective Validation of the ARC-HBR, PRECISE-DAPT, and PARIS Risk Prediction Model in the All-Comer PIONEER IV Trial Presenter: TsungYing Tsai October 28, 2024
Presentation TCT 2024 From ARC-HBR and PRECISE-DAPT to PRECISE-2: Development and Validation of a Novel Universal Bleeding Risk Score Presenter: Marco Valgimigli October 27, 2024